Global Trade Alert
Global Trade Alert

Back to state act

United States of America: U.S. Administration awards $430 million to AstraZeneca for the late-stage development and large-scale manufacturing of COVID-19 therapeutic

Description

On 9 October 2020, as part of the operation warp speed goals, the U.S. Department of Health and Human Services (HHS) and Department of Defense announced awarding USD 486 million to AstraZeneca for the...

Sign in to see full description

Intervention Details

Intervention Type

Financial grant

MAST Chapter

L: Subsidies (excl. export subsidies)

Implementation date

09 Oct 2020

Revocation date

No revocation date

Implementation level

National

Affected flow

Inward

Announced as temporary

No

Eligible firms

firm-specific

Affected Trading Partners

Graph

Table

Affected Sectors

Sign in to access 1 sectors

Affected Products

Sign in to access 10 products

Threads

See all

This intervention is not part of any Thread yet.